CLINICAL TRIAL PARTICIPATION AGREEMENTClinical Trial Participation Agreement • May 12th, 2021 • Big Rock Partners Acquisition Corp. • Pharmaceutical preparations • California
THIS CLINICAL TRIAL PARTICIPATION AGREEMENT (the “Agreement”) is entered into as of this 17 December, 2020 (the “Effective Date”) by and between QUANTUM LEAP HEALTH CARE COLLABORATIVE, a California nonprofit public benefit corporation, located at 3450 California Street, 2nd Floor, San Francisco, CA 94118, (“QLHC”), and NeuroRx, Inc, located at 1201 North Market St. Wilmington, DE 19801 (“Company”). QLHC and Company may each be referenced herein individually as a “Party” and together as the “Parties.”
Clinical Trial Participation AgreementClinical Trial Participation Agreement • June 7th, 2016 • District of Columbia
This Clinical Trial Participation Agreement (the “Agreement”) is entered into by the National Cancer Institute, having its principal place of business at 9609 Medical Center Drive, Rockville, MD 20850 (“NCI”) and [Company Name], having its principal place of business at [Company Address] (“Pharmaceutical Collaborator”), on the other hand. NCI and Pharmaceutical Collaborator may be referred to herein individually as a “Party” and collectively as the “Parties.”
